3.06
price down icon4.97%   -0.16
after-market Dopo l'orario di chiusura: 3.01 -0.05 -1.63%
loading

Evotec Se Adr Borsa (EVO) Ultime notizie

pulisher
Dec 29, 2024

Evotec: Some Recovery Has Come, But Much More Is Expected - Seeking Alpha

Dec 29, 2024
pulisher
Dec 27, 2024

Evotec shares surge 20% on Halozyme's 2 billion euro takeover bid - MSN

Dec 27, 2024
pulisher
Dec 10, 2024

In-Vitro Toxicology Testing Market Projected to Reach USD 30.06 Bn by 2033 - GlobeNewswire Inc.

Dec 10, 2024
pulisher
Nov 25, 2024

Markets Brief: Are Bank Stocks Expensive? - Morningstar

Nov 25, 2024
pulisher
Nov 23, 2024

Evotec SE withdraws acquisition offer By Investing.com - Investing.com South Africa

Nov 23, 2024
pulisher
Nov 22, 2024

Evotec SE withdraws acquisition offer - Investing.com India

Nov 22, 2024
pulisher
Nov 22, 2024

Halozyme ends bid to acquire Evotec at €2 billion valuation - Investing.com

Nov 22, 2024
pulisher
Nov 18, 2024

Halozyme outlines plan to acquire Evotec for €2 billion - Investing.com

Nov 18, 2024
pulisher
Nov 18, 2024

Halozyme outlines plan to acquire Evotec for €2 billion By Investing.com - Investing.com UK

Nov 18, 2024
pulisher
Nov 17, 2024

Halozyme to Fund Proposed Evotec Takeover in Cash, CEO Says - Yahoo Finance

Nov 17, 2024
pulisher
Nov 15, 2024

Evotec SE responds to media speculation - Investing.com India

Nov 15, 2024
pulisher
Nov 15, 2024

Large Pharma Partner Halozyme Therapeutics Offers To Acquire Germany-Based Evotec For ~$2 Billion - AOL

Nov 15, 2024
pulisher
Nov 15, 2024

Halozyme Therapeutics sinks after confirming $2B Evotec buyout offer - Seeking Alpha

Nov 15, 2024
pulisher
Nov 15, 2024

Evotec SE responds to media speculation By Investing.com - Investing.com UK

Nov 15, 2024
pulisher
Nov 14, 2024

Halozyme proposes $2 billion acquisition of Evotec - Investing.com India

Nov 14, 2024
pulisher
Nov 08, 2024

Earnings call: Evotec SE maintains 2024 outlook amid strategic changes - Investing.com India

Nov 08, 2024
pulisher
Nov 07, 2024

Evotec SE ADR earnings beat by $0.02, revenue fell short of estimates - Investing.com

Nov 07, 2024
pulisher
Nov 07, 2024

Evotec Reports Strategic Growth Amidst Revenue Challenges - TipRanks

Nov 07, 2024
pulisher
Nov 05, 2024

Evotec SE Reports 9M 2024 Results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions - Yahoo Finance

Nov 05, 2024
pulisher
Oct 07, 2024

Evotec stock outlook clouded by strategy update delays, warns Jefferies - Investing.com

Oct 07, 2024
pulisher
Sep 23, 2024

KZIAKazia Therapeutics Limited American Depositary Shares Latest Stock News & Market Updates - StockTitan

Sep 23, 2024
pulisher
Aug 23, 2024

Stock Information - Evotec

Aug 23, 2024
pulisher
Aug 23, 2024

Annual General Meeting - Evotec

Aug 23, 2024
pulisher
Aug 23, 2024

Investor Relations - Evotec

Aug 23, 2024
pulisher
Aug 14, 2024

Bristol Myers' German Partner Evotec Plans Layoffs, Cites 'Challenging Revenues, Profitability' - Yahoo Finance

Aug 14, 2024
pulisher
Aug 13, 2024

Dozens of US Stocks Are Newly Undervalued After Market Selloff - Morningstar

Aug 13, 2024
pulisher
Aug 07, 2024

Evotec shares crash 36% on profit warning - Investing.com

Aug 07, 2024
pulisher
May 23, 2024

Earnings call: Evotec SE Q1 2024 results show mixed performance amid challenges - Investing.com

May 23, 2024
pulisher
Apr 08, 2024

T. Rowe Price Raises Stake in Evotec SE - TipRanks

Apr 08, 2024
pulisher
Jan 21, 2012

Together for Medicines That MatterEvotec - Evotec

Jan 21, 2012
pulisher
May 11, 2010

Evotech and Roche subsidiary Genentech enter into drug discovery alliance - Proactive Investors USA

May 11, 2010
pulisher
Sep 09, 2009

Evotec and Biogen Idec in research agreement - Proactive financial news

Sep 09, 2009
$9.15
price down icon 5.86%
$30.06
price down icon 5.05%
$90.92
price down icon 6.47%
$7.62
price down icon 6.62%
$95.65
price down icon 7.03%
$292.46
price down icon 4.85%
Capitalizzazione:     |  Volume (24 ore):